Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 36Neoplasms 32Prostatic Neoplasms 26Colorectal Neoplasms 25Lung Neoplasms 21Carcinoma, Non-Small-Cell Lung 16Hematologic Neoplasms 13Neoplasm Metastasis 10Pancreatic Neoplasms 9Ovarian Neoplasms 8Multiple Myeloma 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Hematopoietic and Lymphatic System Neoplasm 7Stomach Neoplasms 6Carcinoma, Renal Cell 6Anatomic Stage I Breast Cancer AJCC v8 6Uterine Cervical Neoplasms 5Sarcoma 5Glioma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Gastrointestinal Neoplasms 4

Interventions

gadobutrol 1fosaprepitant 1Surveys and Questionnaires 1Standard of Care 1Prochlorperazine 1Ondansetron 1Olanzapine 1Neurokinin-1 Receptor Antagonists 1Imagery, Psychotherapy 1Dexamethasone 1Cryotherapy 1Brachytherapy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gynecologic Cancer × Standard of Care × 1 year × Clear all
NCT03022032 2025-09-09

The HOPE Trial and the SMART Study

Dana-Farber Cancer Institute

Phase NA Completed
102 enrolled 30 charts
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡